DIFFUSE INTRINSIC PONTINE GLIOMAS (DIPG)

Clinical trials for DIFFUSE INTRINSIC PONTINE GLIOMAS (DIPG) explained in plain language.

Never miss a new study

Get alerted when new DIFFUSE INTRINSIC PONTINE GLIOMAS (DIPG) trials appear

Sign up with your email to follow new studies for DIFFUSE INTRINSIC PONTINE GLIOMAS (DIPG), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

New hope for kids with devastating brain cancer

Disease control Recruiting now

This study is testing an oral medication called ACT001 in children and young adults with two types of aggressive brain tumors: diffuse intrinsic pontine glioma (DIPG) and H3K27-altered high-grade glioma (HGG). The main goals are to see if the drug is safe and if it helps patients…

Matched conditions: DIFFUSE INTRINSIC PONTINE GLIOMAS (DIPG)

Phase: PHASE2 • Sponsor: Nationwide Children's Hospital • Aim: Disease control

Last updated Mar 27, 2026 12:38 UTC

DIFFUSE INTRINSIC PONTINE GLIOMAS (DIPG)

Get alerted when new DIFFUSE INTRINSIC PONTINE GLIOMAS (DIPG) trials appear

New hope for kids with devastating brain cancer